Bayer Bubbles Over Proposed Cough/Cold Monograph Amendment
This article was originally published in The Tan Sheet
Executive Summary
FDA is proposing to amend the over-the-counter nasal decongestant drugs monograph to include phenylephrine bitartrate (PEB) in effervescent tablets, according to an announcement published in the Federal Register Nov. 2